nodes	percent_of_prediction	percent_of_DWPC	metapath
Podofilox—Balanoposthitis—Capecitabine—esophageal cancer	0.0378	0.165	CcSEcCtD
Podofilox—Wound secretion—Capecitabine—esophageal cancer	0.0273	0.119	CcSEcCtD
Podofilox—Etoposide—GSTT1—esophageal cancer	0.0148	0.404	CrCbGaD
Podofilox—Localized exfoliation—Capecitabine—esophageal cancer	0.0147	0.0644	CcSEcCtD
Podofilox—TUBA4A—epithelium—esophageal cancer	0.014	0.077	CbGeAlD
Podofilox—TUBA4A—bronchus—esophageal cancer	0.0137	0.0758	CbGeAlD
Podofilox—TUBA4A—smooth muscle tissue—esophageal cancer	0.0134	0.0742	CbGeAlD
Podofilox—Scab—Capecitabine—esophageal cancer	0.0125	0.0545	CcSEcCtD
Podofilox—TUBA4A—trachea—esophageal cancer	0.0123	0.0681	CbGeAlD
Podofilox—TUBA4A—digestive system—esophageal cancer	0.0106	0.0586	CbGeAlD
Podofilox—TOP2A—bronchus—esophageal cancer	0.0102	0.0561	CbGeAlD
Podofilox—TUBB—bronchus—esophageal cancer	0.0101	0.0556	CbGeAlD
Podofilox—TUBB—smooth muscle tissue—esophageal cancer	0.00986	0.0544	CbGeAlD
Podofilox—TUBB—trachea—esophageal cancer	0.00905	0.0499	CbGeAlD
Podofilox—TUBA4A—lung—esophageal cancer	0.00887	0.0489	CbGeAlD
Podofilox—Etoposide—ABCC2—esophageal cancer	0.00857	0.233	CrCbGaD
Podofilox—NR3C1—neck—esophageal cancer	0.00697	0.0384	CbGeAlD
Podofilox—TOP2A—lung—esophageal cancer	0.00656	0.0362	CbGeAlD
Podofilox—TUBB—lung—esophageal cancer	0.0065	0.0358	CbGeAlD
Podofilox—Etoposide—PTGS1—esophageal cancer	0.00649	0.177	CrCbGaD
Podofilox—Tenderness—Cisplatin—esophageal cancer	0.00617	0.027	CcSEcCtD
Podofilox—TUBA4A—lymph node—esophageal cancer	0.00607	0.0334	CbGeAlD
Podofilox—Ulcer—Cisplatin—esophageal cancer	0.00569	0.0249	CcSEcCtD
Podofilox—Pain—Carboplatin—esophageal cancer	0.0056	0.0245	CcSEcCtD
Podofilox—Blister—Capecitabine—esophageal cancer	0.00551	0.024	CcSEcCtD
Podofilox—Skin exfoliation—Cisplatin—esophageal cancer	0.00514	0.0224	CcSEcCtD
Podofilox—Skin ulcer—Capecitabine—esophageal cancer	0.0051	0.0223	CcSEcCtD
Podofilox—Tingling sensation—Capecitabine—esophageal cancer	0.00494	0.0216	CcSEcCtD
Podofilox—NR3C1—epithelium—esophageal cancer	0.00474	0.0261	CbGeAlD
Podofilox—NR3C1—bronchus—esophageal cancer	0.00467	0.0257	CbGeAlD
Podofilox—CYP2C19—digestive system—esophageal cancer	0.00461	0.0254	CbGeAlD
Podofilox—NR3C1—smooth muscle tissue—esophageal cancer	0.00457	0.0252	CbGeAlD
Podofilox—TOP2A—lymph node—esophageal cancer	0.00449	0.0247	CbGeAlD
Podofilox—TUBB—lymph node—esophageal cancer	0.00445	0.0245	CbGeAlD
Podofilox—Skin discolouration—Capecitabine—esophageal cancer	0.00439	0.0192	CcSEcCtD
Podofilox—Ulcer—Capecitabine—esophageal cancer	0.0042	0.0183	CcSEcCtD
Podofilox—NR3C1—trachea—esophageal cancer	0.00419	0.0231	CbGeAlD
Podofilox—Inflammation—Capecitabine—esophageal cancer	0.00409	0.0179	CcSEcCtD
Podofilox—Skin ulcer—Methotrexate—esophageal cancer	0.00379	0.0166	CcSEcCtD
Podofilox—Skin exfoliation—Capecitabine—esophageal cancer	0.00379	0.0165	CcSEcCtD
Podofilox—Etoposide—PTGS2—esophageal cancer	0.00371	0.101	CrCbGaD
Podofilox—NR3C1—digestive system—esophageal cancer	0.00361	0.0199	CbGeAlD
Podofilox—Skin discolouration—Methotrexate—esophageal cancer	0.00327	0.0143	CcSEcCtD
Podofilox—Swelling—Capecitabine—esophageal cancer	0.00327	0.0143	CcSEcCtD
Podofilox—Etoposide—ABCB1—esophageal cancer	0.00315	0.0858	CrCbGaD
Podofilox—Ulcer—Methotrexate—esophageal cancer	0.00312	0.0136	CcSEcCtD
Podofilox—Inflammation—Methotrexate—esophageal cancer	0.00305	0.0133	CcSEcCtD
Podofilox—Dermatitis bullous—Capecitabine—esophageal cancer	0.00301	0.0132	CcSEcCtD
Podofilox—NR3C1—lung—esophageal cancer	0.00301	0.0166	CbGeAlD
Podofilox—Skin exfoliation—Methotrexate—esophageal cancer	0.00282	0.0123	CcSEcCtD
Podofilox—CYP3A4—digestive system—esophageal cancer	0.00273	0.015	CbGeAlD
Podofilox—Dry skin—Capecitabine—esophageal cancer	0.00264	0.0115	CcSEcCtD
Podofilox—Immune system disorder—Cisplatin—esophageal cancer	0.00244	0.0107	CcSEcCtD
Podofilox—Erythema—Cisplatin—esophageal cancer	0.00235	0.0103	CcSEcCtD
Podofilox—Haematuria—Capecitabine—esophageal cancer	0.00212	0.00925	CcSEcCtD
Podofilox—NR3C1—lymph node—esophageal cancer	0.00206	0.0114	CbGeAlD
Podofilox—Haemoglobin—Capecitabine—esophageal cancer	0.002	0.00875	CcSEcCtD
Podofilox—Haemorrhage—Capecitabine—esophageal cancer	0.00199	0.0087	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.00199	0.00869	CcSEcCtD
Podofilox—Oedema—Cisplatin—esophageal cancer	0.00192	0.00839	CcSEcCtD
Podofilox—Skin disorder—Cisplatin—esophageal cancer	0.00187	0.00815	CcSEcCtD
Podofilox—Immune system disorder—Capecitabine—esophageal cancer	0.0018	0.00786	CcSEcCtD
Podofilox—Erythema—Capecitabine—esophageal cancer	0.00173	0.00758	CcSEcCtD
Podofilox—Paraesthesia—Cisplatin—esophageal cancer	0.00172	0.00753	CcSEcCtD
Podofilox—Pain—Cisplatin—esophageal cancer	0.00164	0.00717	CcSEcCtD
Podofilox—Haematuria—Methotrexate—esophageal cancer	0.00158	0.00688	CcSEcCtD
Podofilox—Haemoglobin—Methotrexate—esophageal cancer	0.00149	0.00651	CcSEcCtD
Podofilox—Haemorrhage—Methotrexate—esophageal cancer	0.00148	0.00648	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.00147	0.00641	CcSEcCtD
Podofilox—Oedema—Capecitabine—esophageal cancer	0.00142	0.00618	CcSEcCtD
Podofilox—Skin disorder—Capecitabine—esophageal cancer	0.00138	0.00601	CcSEcCtD
Podofilox—Immune system disorder—Methotrexate—esophageal cancer	0.00134	0.00585	CcSEcCtD
Podofilox—Erythema—Methotrexate—esophageal cancer	0.00129	0.00564	CcSEcCtD
Podofilox—Insomnia—Capecitabine—esophageal cancer	0.00128	0.00559	CcSEcCtD
Podofilox—Paraesthesia—Capecitabine—esophageal cancer	0.00127	0.00555	CcSEcCtD
Podofilox—Vomiting—Cisplatin—esophageal cancer	0.00122	0.00533	CcSEcCtD
Podofilox—Rash—Cisplatin—esophageal cancer	0.00121	0.00529	CcSEcCtD
Podofilox—Pain—Capecitabine—esophageal cancer	0.00121	0.00529	CcSEcCtD
Podofilox—Dermatitis—Cisplatin—esophageal cancer	0.00121	0.00528	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.00109	0.00477	CcSEcCtD
Podofilox—Skin disorder—Methotrexate—esophageal cancer	0.00102	0.00447	CcSEcCtD
Podofilox—Pruritus—Capecitabine—esophageal cancer	0.001	0.00438	CcSEcCtD
Podofilox—Insomnia—Methotrexate—esophageal cancer	0.000953	0.00416	CcSEcCtD
Podofilox—Paraesthesia—Methotrexate—esophageal cancer	0.000946	0.00413	CcSEcCtD
Podofilox—Dizziness—Capecitabine—esophageal cancer	0.000936	0.00409	CcSEcCtD
Podofilox—Pain—Methotrexate—esophageal cancer	0.000901	0.00394	CcSEcCtD
Podofilox—Vomiting—Capecitabine—esophageal cancer	0.0009	0.00393	CcSEcCtD
Podofilox—Rash—Capecitabine—esophageal cancer	0.000893	0.0039	CcSEcCtD
Podofilox—Dermatitis—Capecitabine—esophageal cancer	0.000892	0.0039	CcSEcCtD
Podofilox—Headache—Capecitabine—esophageal cancer	0.000887	0.00387	CcSEcCtD
Podofilox—TUBB—Cell Cycle, Mitotic—BUB1B—esophageal cancer	0.000818	0.00148	CbGpPWpGaD
Podofilox—TOP2A—Mitotic G1-G1/S phases—RB1—esophageal cancer	0.00081	0.00147	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—HIST1H2BM—esophageal cancer	0.00081	0.00146	CbGpPWpGaD
Podofilox—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—esophageal cancer	0.00081	0.00146	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—PSME1—esophageal cancer	0.000803	0.00145	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—PSME2—esophageal cancer	0.000803	0.00145	CbGpPWpGaD
Podofilox—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—esophageal cancer	0.000781	0.00141	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—HSPA5—esophageal cancer	0.00078	0.00141	CbGpPWpGaD
Podofilox—CYP2C19—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.000773	0.0014	CbGpPWpGaD
Podofilox—CYP2C19—Biological oxidations—ADH1B—esophageal cancer	0.000769	0.00139	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—CALR—esophageal cancer	0.000756	0.00137	CbGpPWpGaD
Podofilox—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREBBP—esophageal cancer	0.00075	0.00136	CbGpPWpGaD
Podofilox—Pruritus—Methotrexate—esophageal cancer	0.000746	0.00326	CcSEcCtD
Podofilox—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—esophageal cancer	0.000744	0.00135	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—CREBBP—esophageal cancer	0.000743	0.00134	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—GHRL—esophageal cancer	0.000743	0.00134	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—CDKN2A—esophageal cancer	0.000738	0.00134	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—ABL1—esophageal cancer	0.000734	0.00133	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—BUB1B—esophageal cancer	0.000731	0.00132	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—FBXW7—esophageal cancer	0.000731	0.00132	CbGpPWpGaD
Podofilox—CYP2C19—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000727	0.00131	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—HIST1H2BM—esophageal cancer	0.000724	0.00131	CbGpPWpGaD
Podofilox—NR3C1—Regulation of Androgen receptor activity—EP300—esophageal cancer	0.000717	0.0013	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—MAD2L1—esophageal cancer	0.000715	0.00129	CbGpPWpGaD
Podofilox—CYP2C19—Biological oxidations—CYP26A1—esophageal cancer	0.000715	0.00129	CbGpPWpGaD
Podofilox—TOP2A—Mitotic G1-G1/S phases—CDKN2A—esophageal cancer	0.000712	0.00129	CbGpPWpGaD
Podofilox—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—esophageal cancer	0.000712	0.00129	CbGpPWpGaD
Podofilox—CYP3A4—Tryptophan metabolism—CYP1B1—esophageal cancer	0.00071	0.00128	CbGpPWpGaD
Podofilox—CYP2C19—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000705	0.00128	CbGpPWpGaD
Podofilox—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.000702	0.00127	CbGpPWpGaD
Podofilox—Dizziness—Methotrexate—esophageal cancer	0.000697	0.00304	CcSEcCtD
Podofilox—NR3C1—Circadian Clock—EP300—esophageal cancer	0.000696	0.00126	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—CHEK2—esophageal cancer	0.000695	0.00126	CbGpPWpGaD
Podofilox—TOP2A—Retinoblastoma (RB) in Cancer—MYC—esophageal cancer	0.000686	0.00124	CbGpPWpGaD
Podofilox—Vomiting—Methotrexate—esophageal cancer	0.00067	0.00293	CcSEcCtD
Podofilox—CYP3A4—Tryptophan metabolism—CYP19A1—esophageal cancer	0.000667	0.00121	CbGpPWpGaD
Podofilox—CYP2C19—Biological oxidations—GSTO1—esophageal cancer	0.000665	0.0012	CbGpPWpGaD
Podofilox—Rash—Methotrexate—esophageal cancer	0.000665	0.0029	CcSEcCtD
Podofilox—Dermatitis—Methotrexate—esophageal cancer	0.000664	0.0029	CcSEcCtD
Podofilox—Headache—Methotrexate—esophageal cancer	0.00066	0.00288	CcSEcCtD
Podofilox—TOP2A—Circadian rythm related genes—NOS2—esophageal cancer	0.000659	0.00119	CbGpPWpGaD
Podofilox—CYP2C19—Metapathway biotransformation—GSTO1—esophageal cancer	0.000656	0.00119	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—MAD2L1—esophageal cancer	0.00064	0.00116	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—HIF1A—esophageal cancer	0.000629	0.00114	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—PSME2—esophageal cancer	0.000628	0.00114	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—PSME1—esophageal cancer	0.000628	0.00114	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—CCND1—esophageal cancer	0.000624	0.00113	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	0.000619	0.00112	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	0.000616	0.00111	CbGpPWpGaD
Podofilox—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.000614	0.00111	CbGpPWpGaD
Podofilox—TOP2A—Mitotic G1-G1/S phases—CCND1—esophageal cancer	0.000602	0.00109	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—NR1I2—esophageal cancer	0.000594	0.00107	CbGpPWpGaD
Podofilox—TOP2A—Mitotic G1-G1/S phases—CDKN1A—esophageal cancer	0.000582	0.00105	CbGpPWpGaD
Podofilox—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.000577	0.00104	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—EP300—esophageal cancer	0.000574	0.00104	CbGpPWpGaD
Podofilox—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.000574	0.00104	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—BUB1B—esophageal cancer	0.000572	0.00103	CbGpPWpGaD
Podofilox—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.000566	0.00102	CbGpPWpGaD
Podofilox—TOP2A—Retinoblastoma (RB) in Cancer—TP53—esophageal cancer	0.000563	0.00102	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—PSME2—esophageal cancer	0.000562	0.00102	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—PSME1—esophageal cancer	0.000562	0.00102	CbGpPWpGaD
Podofilox—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.000547	0.000989	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—HIF1A—esophageal cancer	0.000544	0.000983	CbGpPWpGaD
Podofilox—CYP2C19—Biological oxidations—ALDH2—esophageal cancer	0.000542	0.00098	CbGpPWpGaD
Podofilox—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.000539	0.000975	CbGpPWpGaD
Podofilox—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—esophageal cancer	0.000537	0.000971	CbGpPWpGaD
Podofilox—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.000532	0.000963	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—esophageal cancer	0.000532	0.000962	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	0.000531	0.000961	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—NOS2—esophageal cancer	0.000529	0.000957	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—ADH7—esophageal cancer	0.000528	0.000954	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	0.000516	0.000933	CbGpPWpGaD
Podofilox—CYP2C19—Biological oxidations—GSTT1—esophageal cancer	0.000516	0.000932	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—RB1—esophageal cancer	0.000512	0.000926	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—BUB1B—esophageal cancer	0.000511	0.000925	CbGpPWpGaD
Podofilox—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—esophageal cancer	0.000511	0.000924	CbGpPWpGaD
Podofilox—CYP2C19—Biological oxidations—CYP2A6—esophageal cancer	0.00051	0.000922	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—EP300—esophageal cancer	0.000506	0.000915	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	0.000505	0.000913	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—MYC—esophageal cancer	0.0005	0.000905	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—RB1—esophageal cancer	0.0005	0.000904	CbGpPWpGaD
Podofilox—CYP2C19—Arachidonic acid metabolism—PTGS2—esophageal cancer	0.000497	0.0009	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—CHEK2—esophageal cancer	0.000486	0.000879	CbGpPWpGaD
Podofilox—CYP2C19—Biological oxidations—PTGS1—esophageal cancer	0.000483	0.000874	CbGpPWpGaD
Podofilox—TOP2A—Mitotic G1-G1/S phases—MYC—esophageal cancer	0.000483	0.000873	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—CREBBP—esophageal cancer	0.000475	0.00086	CbGpPWpGaD
Podofilox—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.000465	0.000841	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—PIK3CA—esophageal cancer	0.000465	0.00084	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—ADH1B—esophageal cancer	0.000463	0.000837	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	0.000456	0.000825	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—RB1—esophageal cancer	0.000447	0.000808	CbGpPWpGaD
Podofilox—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—esophageal cancer	0.000445	0.000805	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—CREBBP—esophageal cancer	0.000444	0.000803	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	0.000441	0.000798	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—CDKN2A—esophageal cancer	0.000439	0.000795	CbGpPWpGaD
Podofilox—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000437	0.000791	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	0.00043	0.000778	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—NOS3—esophageal cancer	0.000426	0.00077	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—RB1—esophageal cancer	0.000425	0.000769	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000424	0.000767	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	0.00042	0.000759	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—TP53—esophageal cancer	0.000411	0.000743	CbGpPWpGaD
Podofilox—CYP2C19—Biological oxidations—CYP1B1—esophageal cancer	0.000411	0.000743	CbGpPWpGaD
Podofilox—CYP2C19—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000405	0.000733	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—EP300—esophageal cancer	0.000403	0.000729	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	0.0004	0.000723	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000396	0.000717	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	0.000394	0.000713	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—CDKN2A—esophageal cancer	0.000393	0.00071	CbGpPWpGaD
Podofilox—CYP2C19—Biological oxidations—CYP19A1—esophageal cancer	0.000386	0.000698	CbGpPWpGaD
Podofilox—CYP2C19—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000381	0.000689	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—RB1—esophageal cancer	0.00038	0.000687	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—SMG6—esophageal cancer	0.000377	0.000682	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—CDKN2A—esophageal cancer	0.000374	0.000676	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—NOTCH3—esophageal cancer	0.000373	0.000674	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—CCND1—esophageal cancer	0.000371	0.000671	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—CDKN1A—esophageal cancer	0.000368	0.000665	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	0.000366	0.000661	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—TP53—esophageal cancer	0.000362	0.000655	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—CDKN1A—esophageal cancer	0.000359	0.000649	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	0.000358	0.000647	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—EP300—esophageal cancer	0.000342	0.000618	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—NOTCH2—esophageal cancer	0.000334	0.000605	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—CDKN2A—esophageal cancer	0.000334	0.000604	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—CCND1—esophageal cancer	0.000332	0.0006	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	0.000326	0.000589	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—EP300—esophageal cancer	0.000324	0.000585	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—CDKN1A—esophageal cancer	0.000321	0.000581	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—CCND1—esophageal cancer	0.000316	0.000571	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	0.00031	0.000561	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	0.00031	0.000561	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	0.000306	0.000554	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—EP300—esophageal cancer	0.000306	0.000552	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—CDKN1A—esophageal cancer	0.000305	0.000552	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—EP300—esophageal cancer	0.000302	0.000547	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	0.0003	0.000543	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—MYC—esophageal cancer	0.000298	0.000538	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—RB1—esophageal cancer	0.000297	0.000538	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	0.000291	0.000525	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—EP300—esophageal cancer	0.000291	0.000525	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—TP53—esophageal cancer	0.000288	0.000521	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—NR1I2—esophageal cancer	0.000286	0.000517	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—CCND1—esophageal cancer	0.000282	0.00051	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—SMAD4—esophageal cancer	0.000281	0.000508	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—CDKN1A—esophageal cancer	0.000273	0.000494	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000268	0.000484	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—MYC—esophageal cancer	0.000266	0.000481	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—RB1—esophageal cancer	0.000266	0.000481	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—CDKN2A—esophageal cancer	0.000261	0.000473	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—EP300—esophageal cancer	0.00026	0.00047	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—MYC—esophageal cancer	0.000253	0.000458	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	0.000247	0.000447	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—HIST1H2BM—esophageal cancer	0.000245	0.000443	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000244	0.000441	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—PIK3CA—esophageal cancer	0.000239	0.000433	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—CDKN2A—esophageal cancer	0.000234	0.000422	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000234	0.000422	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	0.000232	0.00042	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—TP53—esophageal cancer	0.000232	0.000419	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000229	0.000414	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—MYC—esophageal cancer	0.000226	0.000409	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—CCND1—esophageal cancer	0.000221	0.000399	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—TP53—esophageal cancer	0.000219	0.000395	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—CDKN1A—esophageal cancer	0.000214	0.000386	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—BLVRB—esophageal cancer	0.000208	0.000375	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—SLC52A3—esophageal cancer	0.000208	0.000375	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—NOTCH1—esophageal cancer	0.000207	0.000374	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—EP300—esophageal cancer	0.000203	0.000367	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—CCND1—esophageal cancer	0.000197	0.000357	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—CDKN1A—esophageal cancer	0.000191	0.000345	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—PSME1—esophageal cancer	0.00019	0.000344	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—PSME2—esophageal cancer	0.00019	0.000344	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—CREBBP—esophageal cancer	0.000188	0.000339	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—TP53—esophageal cancer	0.000186	0.000336	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000186	0.000335	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—EP300—esophageal cancer	0.000182	0.000329	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—NOTCH3—esophageal cancer	0.000179	0.000325	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—MYC—esophageal cancer	0.000177	0.00032	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—SLC10A2—esophageal cancer	0.000176	0.000319	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CA1—esophageal cancer	0.000176	0.000319	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CA2—esophageal cancer	0.000161	0.000292	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—NOTCH2—esophageal cancer	0.000161	0.000291	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—MYC—esophageal cancer	0.000158	0.000286	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000158	0.000285	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PLCE1—esophageal cancer	0.00015	0.000271	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ADH7—esophageal cancer	0.00015	0.000271	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000148	0.000268	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—SMAD4—esophageal cancer	0.000135	0.000244	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ADH1B—esophageal cancer	0.000132	0.000238	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—TP53—esophageal cancer	0.00013	0.000235	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—TYMP—esophageal cancer	0.000126	0.000227	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—BLVRB—esophageal cancer	0.000125	0.000226	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—SLC52A3—esophageal cancer	0.000125	0.000226	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CYP26A1—esophageal cancer	0.000122	0.000221	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ALOX15—esophageal cancer	0.000119	0.000216	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—TPI1—esophageal cancer	0.000114	0.000206	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GSTO1—esophageal cancer	0.000114	0.000206	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—MYC—esophageal cancer	0.000111	0.000201	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ALDOB—esophageal cancer	0.000109	0.000197	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CA1—esophageal cancer	0.000106	0.000192	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—SLC10A2—esophageal cancer	0.000106	0.000192	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GAPDH—esophageal cancer	0.000105	0.00019	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CRABP1—esophageal cancer	0.000104	0.000188	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—NOTCH1—esophageal cancer	9.96e-05	0.00018	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GNG7—esophageal cancer	9.89e-05	0.000179	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CA2—esophageal cancer	9.71e-05	0.000176	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ALDH2—esophageal cancer	9.27e-05	0.000168	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—CREBBP—esophageal cancer	9.03e-05	0.000163	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ADH7—esophageal cancer	9.02e-05	0.000163	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PLCE1—esophageal cancer	9.02e-05	0.000163	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GSTT1—esophageal cancer	8.82e-05	0.000159	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CYP2A6—esophageal cancer	8.72e-05	0.000158	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	8.68e-05	0.000157	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PTGS1—esophageal cancer	8.26e-05	0.000149	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ENO1—esophageal cancer	8.26e-05	0.000149	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PSME2—esophageal cancer	8.14e-05	0.000147	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PSME1—esophageal cancer	8.14e-05	0.000147	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ADH1B—esophageal cancer	7.91e-05	0.000143	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—TYMP—esophageal cancer	7.56e-05	0.000137	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CYP26A1—esophageal cancer	7.36e-05	0.000133	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ALOX15—esophageal cancer	7.17e-05	0.00013	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	7.11e-05	0.000129	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CYP1B1—esophageal cancer	7.03e-05	0.000127	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GSTO1—esophageal cancer	6.84e-05	0.000124	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—TPI1—esophageal cancer	6.84e-05	0.000124	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CYP19A1—esophageal cancer	6.61e-05	0.000119	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ALDOB—esophageal cancer	6.56e-05	0.000119	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GAPDH—esophageal cancer	6.31e-05	0.000114	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CRABP1—esophageal cancer	6.25e-05	0.000113	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—HMOX1—esophageal cancer	6.03e-05	0.000109	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GNG7—esophageal cancer	5.95e-05	0.000108	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	5.91e-05	0.000107	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ABCB1—esophageal cancer	5.79e-05	0.000105	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ALDH2—esophageal cancer	5.57e-05	0.000101	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—MYC—esophageal cancer	5.36e-05	9.7e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GSTT1—esophageal cancer	5.3e-05	9.59e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CYP2A6—esophageal cancer	5.24e-05	9.48e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PTGS1—esophageal cancer	4.97e-05	8.98e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ENO1—esophageal cancer	4.97e-05	8.98e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PSME2—esophageal cancer	4.9e-05	8.85e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PSME1—esophageal cancer	4.9e-05	8.85e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.37e-05	7.91e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CYP1B1—esophageal cancer	4.22e-05	7.64e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CYP19A1—esophageal cancer	3.97e-05	7.18e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CREBBP—esophageal cancer	3.87e-05	6.99e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—HMOX1—esophageal cancer	3.62e-05	6.55e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ABCB1—esophageal cancer	3.48e-05	6.29e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—NOS3—esophageal cancer	3.46e-05	6.26e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PTGS2—esophageal cancer	3.17e-05	5.73e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—EP300—esophageal cancer	2.63e-05	4.76e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CREBBP—esophageal cancer	2.33e-05	4.2e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—NOS3—esophageal cancer	2.08e-05	3.76e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PIK3CA—esophageal cancer	1.95e-05	3.52e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PTGS2—esophageal cancer	1.9e-05	3.44e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—EP300—esophageal cancer	1.58e-05	2.86e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.17e-05	2.12e-05	CbGpPWpGaD
